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ABSTRACT
The anatomical distribution of the transcript encoding calcyon, a 24 kDa membrane
protein associated with coupling D1-like dopamine receptor activation to potentiated intra-
cellular calcium release, was examined using in situ hybridization in the macaque brain.
Calcyon mRNA is found to be abundantly distributed throughout the primate brain. In
neocortex, moderately dense, diffuse signal is found in all areas, with increased intensity
present in a superficial isodense band corresponding generally to cortical layers II and III.
Increased intensity of signal is also seen in the pyramidal cell layers of medial prefrontal and
anterior cingulate cortex. Calcyon mRNA is present abundantly in subcortical limbic areas
such as the nucleus accumbens, septum, hypothalamus, amygdala, and hippocampus. Mod-
erate calcyon transcript expression is seen in caudate and putamen, with lower levels in
globus pallidus. Thalamic nuclei, including the reticular nucleus, express low to moderate
levels. Very dense expression is noted in the substantia nigra pars compacta. Numerous
brainstem regions express this transcript, notably monoaminergic nuclei including the locus
coeruleus and dorsal raphe. The cerebellum has detectable levels of expression in both cortex
and deep nuclei. Although calcyon is hypothesized as a means for D1-like receptors to
modulate “cross-talk” with other neurotransmitter receptor systems, it is notable that abun-
dant calcyon transcript is detected in brain regions not associated with D1-like neurotrans-
mission, particularly the substantia nigra pars compacta and other dopamine-synthesizing
cell groups. A substantial proportion of this may relate to the reported association of calcyon
with the D5 receptor, or in addition, may suggest that calcyon has a wider role as a regulator
of intracellular signal transduction. J. Comp. Neurol. 468:264–276, 2004.
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Calcyon is a 24 kDa membrane protein which was re-
cently identified on the basis of its association with the D1
dopamine receptor in an in vitro assay (Lezcano et al.,
2000). It has been shown that in the presence of calcyon, in
vitro stimulation of cells with D1 agonists will potentiate
the intracellular calcium flux stimulated by activation of
the Gq/11 signaling pathways, such as that stimulated by
muscarinic cholinergic and metabotropic glutamate recep-
tors, provided that the latter mechanisms have already
been “primed” by their respective agonists. This process
has been hypothesized as a means by which dopamine
binding at D1 receptors is able to modulate intracellular
calcium ion concentrations in addition to the better-
characterized Gs-dependent signal transduction mecha-
nism of increasing intracellular cyclic AMP concentra-
tions. Lezcano and Bergson (2002) demonstrate that this
mechanism is able to regulate the excitability of dissoci-
ated hippocampal and neocortical neurons in a cAMP-
independent manner when these cells have been previ-
ously stimulated with Gq/11-associated agonists. Calcyon
appears to allow any of several Gq- or G11-coupled neu-
rotransmitter receptors to modulate cellular responses to
dopamine. Effective priming responses have been demon-
strated with applications of muscarinic cholinergic,
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metabotropic glutamatergic, serotonergic, and alpha1 ad-
renergic agonists. The specific means by which this prim-
ing occurs remains unclear, but its inhibition by a protein
kinase C inhibitor suggests the possibility of the diacyl-
glycerol pathway being involved (Lezcano and Bergson,
2002).
The initial studies characterizing calcyon demonstrated
the expression of calcyon protein in neurons of macaque
striatum, prefrontal cortex, and the CA3 region of hip-
pocampus (Lezcano et al., 2000). A more comprehensive
survey of calcyon mRNA in rat brain by Zelenin et al.
(2002) demonstrated its widespread distribution through-
out the brain, including high levels of expression in the
hypothalamus and cerebellum, in addition to striatal, cor-
tical, and hippocampal regions. Clarification of its specific
localization within these neural systems will be critical in
determining its relevance to the function of the neural
circuitry in these regions, particularly with respect to its
ability to regulate “cross-talk” between disparate intracel-
lular signaling pathways. In this study, we undertook a
detailed survey of the distribution of the transcript encod-
ing calcyon in macaque (Macaca nemestrema) brain as a
prelude to studies of the role calcyon may play in patho-
physiological processes in the human brain.
MATERIALS AND METHODS
Matched 10 m frozen sections were obtained from the
brains of four female macaques (Macaca nemestrema)
ranging in age from 7–13 years at the time of death. These
brains were obtained from the Regional Primate Research
Center of the University of Washington. These animals
had been sacrificed as part of protocols unrelated to the
present study which did not require brain tissue. Protocols
involving these animals were reviewed by the Washington
Regional Primate Research Center Research Review Com-
mittee and by the University of Washington IACUC.
Each brain was blocked in the coronal plane into five 1.5
cm slabs comprising the full extent of the brain from the
frontal pole through the cerebellum and occipital cortex.
Blocks were stored at –80°C until cryostat sectioning.
Sections were mounted onto labeled 2  3-inch poly-L-
lysine-subbed glass microscope slides, desiccated, and
stored at –80°C until their use in hybridization studies.
To generate a subclone for riboprobe synthesis, we am-
plified a unique region of calcyon (NCBI GenBank acces-
sion #AF225903, nucleotide coding region 120–509) from
a human brain cDNA brain library (EdgeBiosystems,
Gaithersburg, MD) using PCR. Amplified cDNA segments
were extracted (QIAquick Gel Extraction Kit, Qiagen, Va-
lencia, CA), subcloned (Zero Blunt TOPO PCR cloning kit,
Invitrogen, Carlsbad, CA) and confirmed by nucleotide
sequencing.
Riboprobes were synthesized using 100 Ci of dried
[35S]-UTP, 2.0 l 5 transcription buffer, 1.0 l 0.1M
DTT, 1.0 l each of 10 mM ATP, CTP, and GTP, 2.0 l
linearized plasmid DNA, 0.5 l RNAse inhibitor, and 1.5
l SP6 RNA polymerase for synthesis of antisense probe,
or T7 RNA polymerase for synthesis of sense probe, then
incubated for 2 hours at 37°C. After this incubation, 1.0 l
DNAse (RNAse-free) was added and incubated for 15 min-
utes at room temperature. The reaction mixture was then
sieved through a 1 ml syringe containing G-50 Sephadex
equilibrated in Tris buffer (100 mM Tris-HCl, pH 7.5, 12.5
mM EDTA, pH 8.0, 150 mM NaCl, and 0.2% SDS), and
100 l fractions were eluted. DTT was added to each
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From each animal, 12–15 mounted, frozen sections, se-
lected to represent the entire rostrocaudal extent of the
brain at 0.5 mm intervals, were removed from –80°C
storage and placed in 4% (weight:vol) formaldehyde at
room temperature for 1 hour. The slides were briefly
washed in 2 SSC (300 mM NaCl/30 mM sodium citrate,
pH 7.2) three times. The slides were placed in 0.1M tri-
ethanolamine, pH 8.0/acetic anhydride, 400:1 (vol:vol), on
a stir plate for 10 minutes. The final wash was in 2 SSC
buffer for 5 minutes, followed by dehydration through
graded alcohols and air drying. A coverslip with 0.4 ml
radiolabeled riboprobe (5  106 cpm), 50% formamide
buffer (50% formamide, 10% dextran sulfate, 3 SSC, 50
mM Na2HPO4 (pH 7.4), 1 Denhardt’s solution, 100
g/ml yeast tRNA) and 0.01M DTT was placed on each
coronal section. Slides were placed in a covered tray lined
with filter paper saturated with 50% formamide and in-
cubated at 55°C overnight. As technical controls, an addi-
tional set of slides containing samples from prefrontal
cortex, thalamus, striatum, hippocampus, or cerebellum
were processed parallel to the above. Each of these slides
was treated with radiolabeled riboprobe as above, half of
the slides receiving sense riboprobe and adjacent sections
receiving antisense riboprobe.
The next day the coverslips were removed and the slides
were placed in 2 SSC for 5 minutes, followed by RNAse
(200 g/ml in 10 mM Tris-HCl, pH 8.0/0.5 M NaCl) at 37°C
for 30 minutes. The slides then underwent the following
washes: 2 SSC at room temperature for 10 minutes; 1
SSC for 10 minutes at room temperature; 0.5 SSC for 10
minutes at room temperature; 0.1 SSC at 55°C for 60
minutes; a second wash in 0.1 SSC at 55°C for 60 min-
utes; and 0.5 SSC for 10 minutes at room temperature.
Sections were dehydrated in graded alcohols and apposed
to Kodak BIOMAX MR film for 5 days, as determined by
results from hybridized test slides run in parallel. Films
were developed automatically in a Kodak X-omat auto-
matic processor. Macroscopic images were acquired from
films using a CCD camera via NIH Image software, v.
1.61.
Selected hybridized slides, including technical controls
hybridized with labeled sense probe, were dipped in
Kodak NTB-2 emulsion diluted 1:1 with sterile water and
warmed to 40°C. Dipped slides were stored in darkness at
4°C. Test slides containing hybridized tissue were also
emulsion-dipped on the same day and stored in individual
slide boxes to be developed at weekly intervals for a de-
termination of exposure time. After 34 days, all slides
were developed by immersion in Kodak D19 developer for
2 minutes, rinsed, fixed in Kodak Rapid Fix for 3 minutes,
and washed in running deionized water. The developed
slides were then counterstained by immersion in cresyl
violet (pH 4.2), followed by decolorization in a series of
ethanol and xylene washes. Slides were coverslipped in
Permount and viewed with a Zeiss microscope. Digital
images were acquired using a CCD camera.
Macroscopic images were individually compared to
plates and diagrams from two macaque atlases (Paxinos
et al., 2000; Martin and Bowden, 2000) for identification of
structures. Using Scion Image software, optical density
measurements relative to background were obtained for
regions of interest in each animal, then averaged across
animals for each region. Average optical density by region
was divided into quartiles and a rating of relative optical
density assigned to each region on a scale of 1 (lowest) to
4 (highest) by quartile. Original images were exported to
Adobe PhotoShop (San Jose, CA) for minor adjustments of
brightness and contrast in final processing of the images
contained herein.
To confirm that the riboprobe specifically identified a
single species of calcyon transcript, a Northern blot con-
taining mRNA from specific brain regions was hybridized
with radiolabeled probe prepared as above, except that 83
Ci of [32P]-UTP was used in place of [35S]-UTP in the
RNA polymerase reaction. Identified regions of macaque
brain were dissected and frozen at –80°C until ready for
use. The brain samples were weighed, then individually
homogenized in 1 ml trizol per 100 mg tissue. Following
centrifugation at 10,000 rpm for 15 minutes, the aqueous
phase was mixed with chloroform and recentrifuged. RNA
was precipitated from this aqueous phase with isopropa-
nol and the resulting pellet washed in 75% ethanol, vor-
texed, recentrifuged at 5,000 rpm for 5 minutes, and resus-
pended in 200 l formamide. After spectrophotometrically
determining the concentration of RNA in each sample, 5
g of RNA in a total volume of 30 l was loaded onto a 1%
agarose/formaldehyde gel and run for 60 minutes at 50
volts. RNA from the gel was then transferred to a Hybond
membrane and fixed by baking the membrane at 80°C for
2 hours. The membrane was washed in 2 SSC and pre-
hybridized at 65°C for 2 hours in 50% formamide buffer
(50% formamide, 10% dextran sulfate, 3 SSC, 50 mM
Na2HPO4 (pH 7.4), 1 Denhardt’s solution, 100 g/ml
yeast tRNA) containing 10% SDS. The membrane was
then incubated with [32P]-labeled riboprobe (1  106 cpm
per ml buffer) overnight at 65°C. The hybridized mem-
brane was washed three times at 65°C in 1 SSC, 1 SSC
containing 0.1% SDS, and 0.1 SSC containing 0.1% SDS.
The membrane was dried and apposed to Kodak BIOMAX
MR film with intensifying screens at –80°C for 6 hours.
RESULTS
Calcyon mRNA is found in a widespread distribution
throughout the primate brain (Fig. 1A–L). Relative ex-
pression by specific region is summarized in Table 1.
Northern blot analysis of calcyon expression in multiple
regions of the brain confirms that the probe used identifies
only a single mRNA species (Fig. 2A). Sections incubated
with sense riboprobe have no significant labeling, while
sections incubated with antisense probe demonstrate spe-
cific labeling (Fig. 2B,C).
In the cerebral cortex, calcyon mRNA is expressed in all
areas and layers of cerebral cortex, with somewhat denser
distribution observed in the anterior cingulate cortex, or-
bital cortex (Fig. 1B), and temporal regions, including
entorhinal cortex (Fig. 1E,F). Although the expression
appears to be present in the full thickness of cerebral
cortex, its distribution in all cortical areas is noticeably
denser in a superficial isodense band, corresponding pri-
marily to layer II of neocortex. In granular cortex, such as
primary visual cortex (Fig. 1L), deeper layers are also
more intensely labeled. Deeper layers are also relatively
more enriched in expression in associative cortical areas,
namely, the anterior cingulate (Fig. 1B), precentral (Fig.
1C), and superior temporal gyri, but not in others, such as
the medial temporal and postcentral gyri (Fig. 1J). There
appears to be relatively less expression in an intermediate
band corresponding to layer III in most areas, most no-
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ticeably in the anterior cingulate, precentral, and insular
cortex (Fig. 1C).
In subcortical regions, the densest expression is found
in the ventral striatum and associated limbic areas such
as nucleus accumbens, substantia innominata, and nu-
cleus of the stria terminalis. Expression is detected in the
septal nuclei, particularly in the lateral septal nucleus,
although less abundantly than in nucleus accumbens.
Moderate calcyon mRNA expression is present throughout
the caudate and putamen (Fig. 3), although it appears to
be substantially less abundant relative to expression in
neocortex and ventral striatal areas. Patchy, extremely
light labeling is visible in the globus pallidus, although
scattered isolated cells are intensely labeled on micro-
scopic examination (Fig. 3C). The claustrum also ex-
presses this transcript at moderate levels.
High levels of expression are visible in all nuclei of the
amygdala, with relatively more expression in the lateral
and medial nuclei. In the hippocampal formation, the den-
tate gyrus is found to have very high expression. Nearly
Fig. 1. A–L: Macroscopic images of film autoradiograms demonstrating distribution of calcyon tran-
script in representative coronal sections of macaque brain. Major structures are labeled according to the
atlas of Martin and Bowden (2000). Scale bars  5 mm in A,E,I.
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all granule cells in the dentate gyrus are labeled for cal-
cyon on microscopic examination (Fig. 4B). All hippocam-
pal pyramidal cell fields demonstrate high levels of cal-
cyon expression (Fig. 4A), although there is a trend toward
a higher level of expression in the CA2 pyramidal field
relative to CA1 and CA3, and a minor trend toward rela-
tively less expression in CA4.
In the thalamus, most nuclei display only low levels of
expression, with the prominent exceptions of the centro-
medial and paraventricular nuclei, which express the
transcript abundantly. The thalamic reticular nucleus
and lateral and medial geniculate nuclei also express de-
tectable calcyon mRNA (Fig. 1G–J). The subthalamic nu-
cleus contains a low but detectable level of expression.
Figure 1 (Continued)
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High levels of calcyon transcript are noted in the medial
habenula and in the medial zona incerta, an area which
contains neurons expressing tyrosine hydroxylase.
Particularly abundant mRNA expression is prominent
throughout the hypothalamus, particularly in the su-
praoptic nucleus, arcuate nucleus, and paraventricular
nucleus (Fig. 5), all of which are areas known to contain
dopamine-synthesizing neurons. Abundant expression is
also present in the mammillary nuclei, ventromedial nu-
cleus, and anterior and lateral hypothalamic areas.
In the midbrain, the highest levels of expression are
noted in the substantia nigra pars compacta, ventral teg-
mental area, and in the dorsal raphe nuclei (Fig. 6A–E).
The central gray substance and reticular formation also
express the transcript at moderate to high levels. The
substantia nigra pars reticulata expresses only low mRNA
levels.
Pontine and medullary regions expressing very high
levels of calcyon mRNA include the locus coeruleus (Fig.
6F), peribrachial nuclei, pontine nuclei, vestibular nuclei,
Figure 1 (Continued)
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and inferior olivary complex. Cerebellar cortex expresses
transcript at moderate levels throughout, although the
vermis appears relatively more enriched in calcyon mRNA
than do lateral cerebellar areas. The deep cerebellar nu-
clei express moderate amounts of transcript. Microscopic
examination of cerebellar labeling reveals concentrations
of silver grains over the Purkinje cells in cerebellar cortex
(Fig. 7).
DISCUSSION
We examined the anatomical distribution of transcripts
coding for calcyon in the macaque brain. Consistent with
a previous report in the rat (Zelenin et al., 2002), we find
calcyon to be distributed widely throughout the brain. As
in the previous report, substantial areas of overlap exist
between the distribution of calcyon and the previously
reported distributions of the D1 and D5 receptor tran-
scripts (Meador-Woodruff et al., 1991; Levey et al., 1993;
Beischlag et al., 1995). However, our study also indicates
that calcyon is expressed in brain areas not known to
express either of these receptors.
Calcyon was initially identified and characterized using
an in vitro assay that specifically sought molecules which
interact with the D1 dopamine receptor (Lezcano et al.,
2000). As a result of these experiments, calcyon has been
presented in the literature as primarily associated with
D1-like receptors (e.g., D1 and D5). The calcyon expres-
sion we observe in regions strongly associated with D1
dopamine signaling, such as the caudate and putamen,
nucleus accumbens, neocortex, and hippocampus, is con-
sistent with this view. We find moderate levels of calcyon
in the caudate and putamen, with denser signal noted in
the substantia innominata and nucleus accumbens. D1
receptors have long been shown to be abundantly ex-
pressed in these areas and are important mediators of
synaptic plasticity in these structures (Kerr and Wickens,
2001). Prior to the identification of calcyon, it had been
reported that D1 agonists may mediate inositol triphos-
phate formation in striatal neurons via the coupling of
D1-like receptors to a Gq-linked mechanism (Wang et al.,
1995). It now seems likely that calcyon has a role in
mediating this process. We also find calcyon to be highly
expressed in the amygdala and hippocampus, other re-
gions in which dopamine signaling is implicated in pro-
cesses of synaptic plasticity (Otmakhova and Lisman,
1996).
Although calcyon expression in the caudate and puta-
men is only moderate, it is noticeably more abundant in
neocortex. Our results indicate a widespread, multilami-
nar expression of calcyon in cortex, with a somewhat
greater density in an isodense band corresponding to layer
II of neocortex. This stands in contrast to the reported
predominance of D1 expression in deeper pyramidal cell
layers in primate (Bergson et al., 1995) and human neo-
cortex (Meador-Woodruff et al., 1996), although D5 tran-
scripts are relatively more enriched in these middle layers
(Meador-Woodruff et al., 1996). Dopamine neurotransmis-
sion in cortex has been demonstrated to have an impor-
tant role in cognition and working memory functions (Wil-
liams and Goldman-Rakic, 1995). Evidence also exists
that long-term depression in prefrontal cortical neurons
requires coactivation of metabotropic glutamate and do-
pamine receptors (Otani and Connor, 1998). Calcyon may
prove to be one of the underlying mechanisms required for
TABLE 1. Relative Expression of Calcyon Transcript by Region
Cortex
Anterior cingulate (ACg) 
Gyrus Rectus (GRe) 
Frontoorbital gyrus (FOG) 
Medial frontal gyrus (MFG) 
Lateral orbital gyrus (LOrG) 
Pre-central gyrus (PrCG) 
Insula (Ins) 
Superior temporal gyrus (STG) 
Middle temporal gyrus (MTG) 
Inferior temporal gyrus (ITG) 
Periamygdaloid area (PA) 
Entorhinal (Ent) 
Post-central gyrus (PoCG) 







Dentate gyrus (DG) 
Subcortex
Nu. of Stria Terminalis (StT) 
Substantia Innominata (Sl) 
Lateral Septal Nu. (LS) 
Medial Septal Nu. (MS) 
Dorsal Septal Nu. (DS) 
Nucleus Accumbens (Acb) 
Caudate (Cd) 
Putamen (Pu) 








Mediodorsal Thalamus (MD) 
Ventral Posterior Thalamus (VPL) 
Ventral Anterior Thalamus (VA) 
Centromedial Thalamus (CM) 
Laterodorsal Thalamus (LD) 
Paraventricular N. of Thalamus (PV) 
Lateral Geniculate (LGN) 
Medial Geniculate (MGN) 
Reticular N. Thalamus (Rt) 
Pulvinar (Pul) 
Zona Incerta (Zl) 
Habenula (Hbn) 
Subthalamic N. (STN) 
Hypothalamus
Anterior hypothalamus (AHA) 
Ventromedial hypothalamus (VMH) 
Supraoptic N. (SO) 
Lateral Hypothalamus (LH) 
Mammilary N. (MM) 
Arcuate N. (ArcH) 
Paraventricular N. (Pa) 
Mesencephalon
Substantia nigra compacta (SNc) 
Substantia nigra reticulata (SNr) 
Ventral tegmental area (VTA) 
Red Nucleus (RPC, RMC) 
Central grey (CG) 
Dorsal raphe (DR) 
Pedunculopontine Nu. (PPT) 
Superior colliculus (SC) 
Pons and Medulla
Pontine Nuclei (Pn) 
Reticular fields (PnC, CMRT) 
Locus Coeruleus (LC) 
Parabrachial nucleus (PBN) 
Vestibular nuclei (Ve) 
Inferior olivary complex (IO) 
N. of solitary tract (NST) 
Spinal trigeminal nucleus (CSp5) 
Cerebellum
Cerebellar Cortex (Lateral) (Cb) 
Cerebellar Cortex (Vermis) (Cb) 
Deep Nuclei (DpCb) 
Key:  highest signal intensity;  heavy signal; , moderate signal; , light
signal.
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this instance of synaptic plasticity through its ability to
allow other neurotransmitters, such as glutamate and
acetylcholine, to regulate the nature of dopamine’s intra-
cellular effects. This modulation may well vary in a
region-specific manner, depending on the relative abun-
dance of the other receptors present. For example, the
higher levels of calcyon expression we observe in cortex
relative to caudate and putamen may indicate that
calcyon-transduced signaling plays a relatively greater
role in cortex. Further evidence for this may be seen in the
observation that calcyon appears to affect calcium flux in
dissociated neocortical and hippocampal neurons differ-
ently than in dissociated striatal neurons (Lezcano and
Bergson, 2002).
In spite of the above instances of concordance with D1
receptor distribution, notable inconsistencies are also ob-
served. In many areas the presence of calcyon transcripts
in areas not associated with D1 signaling can be largely
attributed to an overlap with D5. This is particularly true
in cortex, where the presence of calcyon signal in middle
cortical layers is similar to the reported distribution of D5
transcripts in human brain (Meador-Woodruff et al.,
1996). It is also evident in the hippocampus and associ-
ated temporal cortical regions, where Meador-Woodruff et
al. (1994) demonstrated a near-complete mismatch be-
tween the distributions of D1 and D5 transcripts in hu-
man brain. Although calcyon is expressed abundantly in
the dentate gyrus, all hippocampal pyramidal fields, sub-
iculum, and entorhinal and temporal cortices, D1 is pri-
marily expressed in neocortex and faintly in subiculum
and the CA1 field. In contrast, D5 is expressed at high
levels in the dentate gyrus, CA2, CA3, and CA4 pyramidal
fields, and entorhinal cortex, as well as faintly in CA1 and
subiculum (Meador-Woodruff et al., 1994).
Calcyon is expressed at low to moderate levels in most
thalamic nuclei, with a trend for higher levels of expres-
sion in midline nuclei, notably in the centromedial, para-
ventricular, and parafasicular nuclei. There is prominent
calcyon expression in the thalamic reticular nucleus, as
well as in sensory relay nuclei, such as the lateral and
medial geniculate nuclei. Overall, this pattern of expres-
sion is not consistent with the distribution of mRNAs for
D1 receptors, which are generally expressed at very low
levels in thalamus (Meador-Woodruff, 1994). In addition,
the moderate level of expression in cerebellar cortex, par-
ticularly in the Purkinje cells, is not consistent with pre-
vious findings showing relatively limited D1 mRNA ex-
pression in the cerebellum (Meador-Woodruff, 1994).
The most striking lack of concordance is the abundant
calcyon expression in monoamine-synthesizing neurons,
especially in the substantia nigra, where cell bodies in the
pars compacta are intensely labeled for calcyon. Expres-
sion of D1 receptor mRNA has not been demonstrated in
cell bodies of the substantia nigra pars compacta (SNc),
although D1 receptors have been localized to the neuropil
of the pars reticulata, where they likely are present on
terminals of striatonigral projection neurons (Meador-
Woodruff et al., 1991; Levey et al., 1993; Bergson et al.,
1995). Again, the very high levels of calcyon mRNA ex-
pression in these cells may be indicative of an association
between calcyon and D5 receptors, as suggested by Lez-
cano et al. (2000) and Zelenin et al. (2002). D5 receptor
immunoreactivity and mRNA have been reported in cell
bodies in the SNc in both monkey and human, although at
somewhat lower levels (Beischlag et al., 1995; Bergson et
al., 1995; Ciliax et al., 2000). We also find particularly
high levels of calcyon expression in other monoaminergic
nuclei, especially the dorsal raphe and locus coeruleus.
Fig. 2. Technical controls. A: Northern blot indicating identifica-
tion of single species by radiolabeled antisense riboprobe in multiple
brain regions. B: Film autoradiogram of section at the level of the
thalamus (approx. ac –9 mm) treated with radiolabeled antisense
riboprobe. C: Adjacent section treated with radiolabeled sense ribo-
probe. Pu, putamen; DLG, dorsal lateral geniculate nucleus; SNc,
substantia nigra pars compacta; VPL, ventral posterior lateral nu-
cleus; Ins, insula. Scale bar  2 mm.
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Fig. 4. A: Composite darkfield photomicrograph demonstrating
distribution of calcyon in medial temporal lobe structures at AP level
of ac –7 mm. Scale bar  1 mm. B: Low-power view of high level of
expression in dentate gyrus (DG), with moderate expression in hip-
pocampal subfields (CA1-CA4), subiculum (S), and entorhinal cortex
(EC). Scale bar  1 mm. C: High-power view of CA2 hippocampal
pyramidal field indicated by rectangle in B. Scale bars  0.2 mm.
Fig. 3. Expression of calcyon mRNA in dorsal striatum and globus
pallidus. A: Striatopallidal boundary at low power demonstrating
widespread labeling in dorsal striatum and scattered large neurons in
the globus pallidus. AP level approximately ac –4 mm. Scale bar  1
mm. B: Highlighted region indicated by rectangle in A. Scale bar  0.2
mm. C: Calcyon transcript expression in scattered large neurons in
globus pallidus. Pu, putamen; LGP; lateral globus pallidus. Scale
bars  0.1 mm.
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This also may relate to the association of calcyon with D5
receptors, based on reports of the localization of D5 mRNA
and immunoreactivity in these regions in human, monkey,
and rat (Beischlag et al., 1995; Khan et al., 1995; Ciliax et
al., 2000), or could relate to the presence of other Gq/11-
coupled monoamine receptors on these neurons.
The hypothalamus is also a region in which calcyon
appears to overlap with D5 expression. Calcyon tran-
scripts are abundantly expressed throughout the hypo-
thalamus. Particularly dense labeling is present in the
supraoptic nucleus (SO) and paraventricular nucleus (Pa),
both areas which have been demonstrated to contain pop-
ulations of tyrosine hydroxylase-expressing neurons
(Swanson et al., 1981; Kawano and Daikoku, 1987; Ciliax
et al., 2000). Evidence does exist for both D1 and D5
receptor expression in the supraoptic, suprachiasmatic,
and paraventricular hypothalamic nuclei (Ciliax et al.,
2000), and they are also sites in which c-fos can be induced
by D1-type agonist infusion (Rivkees and Lachowicz,
1997). Similarly, the arcuate nucleus (ArcH) and ventro-
medial hypothalamus (VMH) also express calcyon mRNA
at high levels. These areas are known to be areas in which
dopamine acts via both D1 and D5 receptors to facilitate
female reproductive behaviors in rats (Zhou et al., 1999),
although a dopaminergic role in analogous primate behav-
iors remains to be elucidated. Calcyon may prove to play
an important role in the integration of signaling in these
processes, as the release of certain hypothalamic peptides,
such as gonadotropin-releasing hormone (GnRH), is reg-
ulated by neurotransmitters such as acetylcholine, which
can act to prime the interaction between calcyon and
dopamine receptors. In addition, many of these peptides
are themselves agonists at Gq/11-coupled receptors, leav-
ing open the possibility that peptide neuromodulators can
also “prime” the activation of calcyon for dopamine.
D5 receptor activation has also been implicated in the
calcium-dependent induction of long-term potentiation of
EPSPs in striatal aspiny cholinergic neurons (Suzuki et
al., 2001), it is conceivable that calcyon coupling to D5
receptors could also provide a mechanism for this obser-
vation, and would be consistent with previous observa-
tions of D5 but not D1 receptor expression in cholinergic
Fig. 5. Higher magnification macroscopic image displaying expression of calcyon mRNA in hypothalamic
nuclei. Note very high mRNA expression in supraoptic (SO) and paraventricular (PA) nuclei (A) as well as
abundant expression in ventromedial (VMH) (B,C) and arcuate (Arc) nuclei (C,D). Scale bar  1 mm.
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Fig. 6. Calcyon mRNA is abundantly expressed in multiple
monoamine-synthesizing nuclei. A,B: Dorsal raphe nucleus (DR). AP
level  ac –14 mm. C,D: Substantia nigra, pars compacta (SNc). AP
level  ac –8 mm. E: Substantia nigra and ventral tegmental area
(VTA). AP level  ac –10.5 mm. F: Locus coeruleus. AP level  ac –19
mm. Rectangles highlighted in A and C indicate area shown at higher
power in B and D, respectively. Scale bar  1 mm in A (applies to
A,C,E,F); 0.2 mm in B (applies to B,D).
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cells in this area (Rappaport et al., 1993; Bergson et al.,
1995). Although we do not offer specific evidence to indi-
cate the neurochemical identity of individual striatal cells,
we do find scattered large calcyon-positive perikarya in
the globus pallidus (GP) which are distributed similarly to
the cholinergic cells in this region. As D1 receptors are not
known to be expressed in the GP, whereas D5 receptors
are present at low levels (Beischlag et al., 1995), it is
possible that this represents a coexpression of calcyon
with D5 receptors in this region. Further association of
calcyon with the D5 receptor may also be evident in the
high level of expression seen in the thalamic parafasicular
nucleus, which is indicated by a previous study as the only
thalamic nucleus which expresses appreciable D5 mRNA
in rat brain (Meador-Woodruff et al., 1992).
As in an earlier report of calcyon distribution in rat
brain (Zelenin et al., 2002), this study in primate reveals
areas in which the distribution of calcyon overlaps with
those reported for D1-like receptors, both D1 and D5, in
brain. In many areas, the presence of calcyon transcripts
in areas not associated with D1 transcripts can largely be
attributed to an overlap with D5. Of these, it is striking
that the most intense calcyon signals are observed in
areas where D5 predominates, such as in the hippocam-
pus and the monoaminergic nuclei. Nevertheless, we also
note the presence of calcyon expression in some areas not
associated with either D1 or D5 signaling. There are mod-
erate to high levels of calcyon expressed in several brain-
stem regions, particularly the vestibular nuclei, nucleus of
the solitary tract, and pontine and medullary reticular
fields, which are not known to express D1 or D5 message.
Likewise, in the cerebellum, although studies have re-
ported D5 protein expression by Purkinje cells in rat and
human (Ciliax et al., 2000; Khan et al., 2000), most D5
immunoreactivity has been observed in neuropil, sugges-
tive of an origin in extracerebellar neurons such as the
inferior olivary complex, which has been shown to express
D5 protein.
We believe that further studies examining the colocal-
ization of calcyon with specific Gq- or G11-coupled neuro-
transmitter receptors such as muscarinic acetylcholine,
serotonin (5HT-1C, 5HT-2), and metabotropic glutamate
receptors will highlight other specific regions or systems
within the brain in which these interactions play an im-
portant physiologic role. It is interesting that comparing
the distribution of calcyon to the reported distributions of
the alpha subunits of Gq and G11 (Friberg et al., 1997;
Mailleux et al., 1992) reveals a number of similarities: a
widespread, multilaminar cortical expression, moderate
striatal expression, abundant hypothalamic expression,
and widespread brainstem expression, including localiza-
tion in monoaminergic nuclei. This is not surprising, given
the variety of neurotransmitters which couple to Gq or
G11 as signal transduction mechanisms, but does call
attention to the complexity of the neurotransmitter ac-
tions of which calcyon is a part.
Overall, our findings confirm the relationship between
calcyon and dopaminergic signaling at D1 and D5 recep-
tors, while suggesting the possibility of a wider role in
intracellular mechanisms which coordinate and regulate
signaling by multiple neurotransmitters, particularly
neuromodulators. Whether this wider role involves asso-
ciations with other G-protein-coupled monoaminergic or
peptidergic receptors, or involvement in an alternative
function such as protein trafficking, remains a question
for further research. In general, the understanding of
these mechanisms is likely to have important clinical im-
plications. For example, it has become increasingly appar-
ent that psychiatric diseases such as schizophrenia are
best understood as dysregulations of multiple interacting
neurotransmitter systems, rather than as a dysfunction of
a single neurotransmitter or receptor. Koh et al. (2003),
have recently shown that calcyon is measurably upregu-
lated in the dorsolateral prefrontal cortex in schizophre-
nia. Future examination of the function and regulation of
molecules such as calcyon will take on greater importance
in our understanding of the complex pathophysiology of
mental illness.
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